Investment in uFraction8 Limited led by Foresight with participation from Old College Capital, Scottish Enterprise, Alwyn Capital and Thia Ventures. uFraction8 is commercialising a pioneering microfluidics-based technology that enables continuous bioprocessing of mammalian cell lines, stem cells and microalgae at scale. This funding will enable further technological development, commercialisation of the technology in Europe and North America and buildout of the team’s sales and manufacturing capabilities.

ADVISORS & FUNDERS